Are there any restrictions or limitations on the use of telemedicine to obtain prescription drugs?

In Washington, the use of telemedicine to obtain prescription drugs is subject to restrictions and limitations such as the patient must have an established relationship with the prescriber and must have been seen by the prescriber in person within the past 24 months. In addition, the prescriber must have a valid DEA number prior to prescribing, obtain informed consent from the patient, and obtain patient history information. Furthermore, the prescriber must determine that the patient’s condition can be appropriately managed by telemedicine, and the prescription must be issued in accordance with state and federal laws, including but not limited to DEA laws. A prescription drug must be prescribed for a “legitimate medical purpose” and only after the prescriber has conducted an appropriate medical evaluation using “acceptable medical practices.” When using telemedicine, the prescriber must ensure that the prescription drug is appropriate for the patient’s clinical condition, that the patient understands the risks and benefits of the drug, and that the patient has access to a pharmacy for the initial fill and refills of the prescription. Lastly, some drugs may not be prescribed via telemedicine. These include controlled substances, medications requiring special handling, prescriptions that need to be compounded, and prescriptions that are part of a clinical trial. In general, the use of telemedicine to obtain prescription drugs is subject to restrictions and limitations. It is important to adhere to the laws in Washington to ensure safe and effective prescribing practices.

Are there any restrictions or limitations on the use of telemedicine to obtain prescription drugs?

Related FAQs

Related Blog Posts